0000898432-24-000085.txt : 20240202
0000898432-24-000085.hdr.sgml : 20240202
20240202164425
ACCESSION NUMBER: 0000898432-24-000085
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
EFFECTIVENESS DATE: 20240202
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Carlyle Group Inc.
CENTRAL INDEX KEY: 0001527166
STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 452832612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15025
FILM NUMBER: 24592269
BUSINESS ADDRESS:
STREET 1: C/O THE CARLYLE GROUP
STREET 2: 1001 PENNSYLVANIA AVENUE, N.W.
CITY: WASHINGTON
STATE: DC
ZIP: 20004
BUSINESS PHONE: 202 729 5626
MAIL ADDRESS:
STREET 1: C/O THE CARLYLE GROUP
STREET 2: 1001 PENNSYLVANIA AVENUE, N.W.
CITY: WASHINGTON
STATE: DC
ZIP: 20004
FORMER COMPANY:
FORMER CONFORMED NAME: Carlyle Group L.P.
DATE OF NAME CHANGE: 20110801
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001527166
XXXXXXXX
12-31-2023
12-31-2023
false
Carlyle Group Inc.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON
DC
20004
13F COMBINATION REPORT
028-15025
000111128
801-52462
0001512910
028-15646
000159215
801-72890
AlpInvest Partners B.V.
Y
Explanatory Note 1: AlpInvest Partners B.V. is an indirectly wholly owned investment adviser of The Carlyle Group Inc. However, The Carlyle Group Inc. does not participate in any investment decision-making of AlpInvest Partners B.V. --
Explanatory Note 2: In August 2022, The Carlyle Group Inc. completed its acquisition of the Abingworth group, a life sciences investment firm. As a result of the acquisition, Abingworth LLP became a relying advisor of Carlyle Investment Management L.L.C.
Jeffrey W. Ferguson
General Counsel
202-729-5626
/s/ Jeffrey W. Ferguson
Washington
DC
02-02-2024
3
25
2079248663
1
0001397144
028-14285
000163213
802-75741
Abingworth LLP
2
0001354120
028-12429
000111128
801-52462
Carlyle Investment Management LLC
3
0001555793
028-15024
000114795
CIM Global, L.L.C.
INFORMATION TABLE
2
informationtable.xml
Adicet Bio Inc
Com
007002108
3976924
2115385
SH
DFND
1
0
2115385
0
Complete Solaria Inc
Com
20460L104
4256112
2745879
SH
DFND
2
0
2745879
0
CubeSmart
Com
229663109
10220175
220500
SH
DFND
2
0
220500
0
Effector Therapeutics Inc
Com
28202V108
2228781
4822114
SH
DFND
1
0
4822114
0
Exicure Inc
Com New
30205M200
163405
281636
SH
DFND
1
0
281636
0
GDS Hldgs Ltd
Sponsored Ads
36165L108
37142334
4072624
SH
DFND
2,3
0
4072624
0
Getty Images Holdings Inc
Cl A Com
374275105
49320175
9394319
SH
DFND
2
0
9394319
0
Hillevax Inc
Com
43157M102
29507700
1838486
SH
DFND
1
0
1838486
0
Invitation Homes Inc
Com
46187W107
16287525
477500
SH
DFND
2
0
477500
0
Jasper Therapeutics Inc
Com
471871103
6669551
8761891
SH
DFND
1
0
8761891
0
Meta Data Limited
Sponsored Ads
68276W400
306006
314400
SH
DFND
2,3
0
314400
0
Molecular Templates Inc
Com New
608550208
49332
13333
SH
DFND
1
0
13333
0
Nucana Plc
Sponsored Adr
67022C106
967000
3333333
SH
DFND
1
0
3333333
0
Phathom Pharmaceuticals Inc
Com
71722W107
31925857
3496808
SH
DFND
1
0
3496808
0
Quidelortho Corp
Com
219798105
918315487
12460183
SH
DFND
2
0
12460183
0
Reneo Pharmaceuticals Inc
Com
75974E103
4318331
2698957
SH
DFND
1
0
2698957
0
Seacor Marine Hldgs Inc
Com
78413P101
16545325
1314164
SH
DFND
2
0
1314164
0
Smart Sh Global Ltd
Ads
83193E102
2409914
4810209
SH
DFND
2,3
0
4810209
0
Soleno Therapeutics Inc
Com
834203309
115038749
2857804
SH
DFND
1
0
2857804
0
Spruce Biosciences Inc
Com
85209E109
8370937
2896518
SH
DFND
1
0
2896518
0
Spyre Therapeutics Inc
Com New
00773J202
203944
9620
SH
DFND
1
0
9620
0
Vera Therapeutics Inc
Cl A
92337R101
22104442
1438155
SH
DFND
1
0
1438155
0
Verona Pharma Plc
Sponsored Ads
925050106
48805950
2457500
SH
DFND
1
0
2457500
0
Vitru Ltd
Com
G9440D103
98444383
6246471
SH
DFND
2,3
0
6246471
0
ZoomInfo Technologies Inc
Common Stock
98980F104
651670324
35244474
SH
DFND
2
0
35244474
0